Workflow
仙乐健康(300791.SZ):2025年中报净利润为1.61亿元、较去年同期上涨4.30%

Group 1 - The company reported a total operating revenue of 2.042 billion yuan, an increase of 51.14 million yuan compared to the same period last year, marking three consecutive years of growth and a year-on-year increase of 2.57% [1] - The net profit attributable to shareholders was 161 million yuan, an increase of 6.644 million yuan compared to the same period last year, achieving two consecutive years of growth and a year-on-year increase of 4.30% [1] - The net cash inflow from operating activities was 160 million yuan, an increase of 45.3736 million yuan compared to the same period last year, representing a year-on-year increase of 39.74% [1] Group 2 - The company's latest debt-to-asset ratio is 53.56% [3] - The latest gross profit margin is 33.18%, an increase of 0.09 percentage points from the previous quarter, achieving three consecutive quarters of growth and a year-on-year increase of 1.14 percentage points, marking two consecutive years of growth [3] - The latest return on equity (ROE) is 6.31% [3] Group 3 - The diluted earnings per share are 0.53 yuan, an increase of 0.02 yuan compared to the same period last year, representing a year-on-year increase of 4.29% [3] - The latest total asset turnover ratio is 0.36 times [3] - The latest inventory turnover ratio is 2.57 times [3] Group 4 - The number of shareholders is 12,100, with the top ten shareholders holding 222 million shares, accounting for 72.07% of the total share capital [3] - The largest shareholder is Guangdong Guanghui Investment Co., Ltd., holding 42.66% of the shares [3] - Other significant shareholders include Lin Peiqing (9.10%), Chen Qiong (5.55%), and Yang Rong (3.22%) [3]